Back to Search Start Over

The Liver in Oncology

Authors :
Paul Y. Kwo
Renu Dhanasekaran
Source :
Clinics in Liver Disease. 21:697-707
Publication Year :
2017
Publisher :
Elsevier BV, 2017.

Abstract

Gastroenterologists and hepatologists will encounter oncology patients who develop abnormal liver tests, patients with hepatic malignancies, and patients with acute and chronic liver disease who require chemotherapy or immediate evaluation. Chemotherapy can cause liver injury owing to toxic effects or idiosyncratic reactions. Immune checkpoint inhibitors may be associated with autoimmune-mediated liver toxicities. Venoocclusive disease requires immediate evaluation. Nodular regenerative hyperplasia is a chronic progressive disorder. Screening and prophylaxis for reactivation of hepatitis B is important to minimize complications in patients receiving chemotherapy. Patients with metastatic lesions can undergo resection or ablation. Hepatic injury may occur in those receiving radiation-based therapies.

Details

ISSN :
10893261
Volume :
21
Database :
OpenAIRE
Journal :
Clinics in Liver Disease
Accession number :
edsair.doi.dedup.....9cb7b52440d5d04a7720c8db13e3fe9a